
TY  - JOUR
TI  - Scientific Section
JO  - Transfusion
VL  - 51
IS  - s3
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.2011.03301_1.x
DO  - doi:10.1111/j.1537-2995.2011.03301_1.x
SP  - 1A
EP  - 236A
PY  - 2011
ER  - 

TY  - JOUR
TI  - Annual Symposium of the Society for the Study of Inborn Errors of Metabolism - Lisboa, Portugal, 2–5 September, 2008
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 31
IS  - S1
SN  - 0141-8955
UR  - https://doi.org/10.1007/s10545-008-9975-0
DO  - doi:10.1007/s10545-008-9975-0
SP  - 1
EP  - 192
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19–22 August 2010, Brighton, UK
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidem. Drug Safe.
VL  - 19
IS  - S1
SN  - 1053-8569
UR  - https://doi.org/10.1002/pds.2019
DO  - doi:10.1002/pds.2019
SP  - S1
EP  - S347
PY  - 2010
ER  - 

TY  - JOUR
AU  - Johnson, Keith A.
AU  - Sperling, Reisa A.
AU  - Gidicsin, Christopher M.
AU  - Carmasin, Jeremy S.
AU  - Maye, Jacqueline E.
AU  - Coleman, Ralph E.
AU  - Reiman, Eric M.
AU  - Sabbagh, Marwan N.
AU  - Sadowsky, Carl H.
AU  - Fleisher, Adam S.
AU  - Murali Doraiswamy, P.
AU  - Carpenter, Alan P.
AU  - Clark, Christopher M.
AU  - Joshi, Abhinay D.
AU  - Lu, Ming
AU  - Grundman, Michel
AU  - Mintun, Mark A.
AU  - Pontecorvo, Michel J.
AU  - Skovronsky, Daniel M.
AU  - AV45-A11 study group
TI  - Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
JO  - Alzheimer's & Dementia
JA  - Alzheimer's & Dementia
VL  - 9
IS  - 5S
SN  - 1552-5260
UR  - https://doi.org/10.1016/j.jalz.2012.10.007
DO  - doi:10.1016/j.jalz.2012.10.007
SP  - S72
EP  - S83
KW  - Mesh
KW  - Alzheimer's disease
KW  - PET
KW  - Amyloid
KW  - Florbetapir
KW  - Amyvid
PY  - 2013
AB  - Objective To evaluate the performance characteristics of florbetapir F18 positron emission tomography (PET) in patients with Alzheimer's disease (AD), mild cognitive impairment (MCI), and healthy control subjects (HCs). Methods Florbetapir PET was acquired in 184 subjects (45 AD patients, 60 MCI patients, and 79 HCs) within a multicenter phase 2 study. Amyloid burden was assessed visually and quantitatively, and was classified as positive or negative. Results Florbetapir PET was rated visually amyloid positive in 76% of AD patients, 38% of MCI patients, and 14% of HCs. Eighty-four percent of AD patients, 45% of MCI patients, and 23% of HCs were classified as amyloid positive using a quantitative threshold. Amyloid positivity and mean cortical amyloid burden were associated with age and apolipoprotein E ε4 carrier status. Conclusions The data are consistent with expected rates of amyloid positivity among individuals with clinical diagnoses of AD and MCI, and indicate the potential value of florbetapir F18 PET as an adjunct to clinical diagnosis.
ER  - 

TY  - JOUR
TI  - Poster Presentations - Poster Session 2: Tuesday, 1 September 2009 - Wednesday, 2 September 2009
JO  - Transplant International
VL  - 22
IS  - s2
SN  - 0934-0874
UR  - https://doi.org/10.1111/j.1432-2277.2009.00963.x
DO  - doi:10.1111/j.1432-2277.2009.00963.x
SP  - 222
EP  - 366
PY  - 2009
ER  - 

C7  - pp. 417-576
TI  - Glossary and Index
SN  - 9781119975892
UR  - https://doi.org/10.1002/9781119977452.index
DO  - doi:10.1002/9781119977452.index
SP  - 417-576
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts-part V (Continue in Part VI)
JO  - Proceedings of the International Society for Magnetic Resonance in Medicine
JA  - Proc. Soc. Magn. Reson. Med.
VL  - 1992
IS  - S3
SN  - 9781119975892
UR  - https://doi.org/10.1002/mrmp.22419920307
DO  - doi:10.1002/mrmp.22419920307
SP  - 2411
EP  - 2921
PY  - 1992
ER  - 

TY  - JOUR
TI  - ABSTRACTS
JO  - Alcoholism: Clinical and Experimental Research
VL  - 20
IS  - s2
SN  - 9781119975892
UR  - https://doi.org/10.1111/j.1530-0277.1996.tb01181.x
DO  - doi:10.1111/j.1530-0277.1996.tb01181.x
SP  - 4A
EP  - 147A
PY  - 1996
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Colorectal Disease
VL  - 7
IS  - s1
SN  - 9781119975892
UR  - https://doi.org/10.1111/j.1463-1318.2005.00843.x
DO  - doi:10.1111/j.1463-1318.2005.00843.x
SP  - 1
EP  - 42
PY  - 2005
ER  - 

TY  - JOUR
AU  - Unwin, C Elizabeth
AU  - Thomson, Neil J
AU  - Gracey, Michael S
TI  - The impact of tobacco smoking and alcohol consumption on Aboriginal mortality in Western Australia, 1989–1991
JO  - Medical Journal of Australia
JA  - Medical Journal of Australia
VL  - 162
IS  - 9
SN  - 9781119975892
UR  - https://doi.org/10.5694/j.1326-5377.1995.tb140009.x
DO  - doi:10.5694/j.1326-5377.1995.tb140009.x
SP  - 475
EP  - 478
PY  - 1995
AB  - Objectives: To compare the estimated death rates associated with alcohol and tobacco use for Australian Aboriginals in Western Australia with those for non-Aboriginals. Method: Deaths attributable to tobacco smoking and alcohol consumption were estimated for 1989?1991 with the aetiological fractions method, using data from the Health Department of Western Australia's mortality database. Results: Tobacco smoking was responsible for 15.4% of all deaths and 13.9% of Aboriginal deaths, and alcohol consumption for 5% and 9.2%, respectively. The age-standardised death rates per 100000 person-years for tobacco and alcohol were: Aboriginal males, 271 and 152; other males, 113 and 29; Aboriginal females, 118 and 56; and other females, 32 and 15. Of those who died as a result of tobacco use, 49% of Aboriginal males and 48% of Aboriginal females died before 55 years of age, compared with 11% and 10%, respectively, in non-Aboriginal males. For alcohol-related deaths, 62% of Aboriginal males and 70% of Aboriginal females died before 55 years of age, compared with 35% and 23%, respectively, in non-Aboriginals. Conclusion: During 1989?1991 tobacco smoking and alcohol consumption were responsible for much higher death rates among Aboriginals than among non-Aboriginals in Western Australia.
ER  - 

AU  - Jacob, H.
C7  - pp. 75-93
TI  - Muscular Twitchings in Alzheimer's Disease
SN  - 9780470662793
UR  - https://doi.org/10.1002/9780470719749.ch6
DO  - doi:10.1002/9780470719749.ch6
SP  - 75-93
KW  - alzheimer's disease
KW  - creutzfeldt-jakob disease
KW  - muscular twitching
KW  - aphasia
KW  - rhythmic extension
PY  - 1995
AB  - Summary This chapter contains section titled: References
ER  - 

TY  - JOUR
TI  - Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders
JO  - Movement Disorders
JA  - Mov. Disord.
VL  - 23
IS  - S1
SN  - 9780470662793
UR  - https://doi.org/10.1002/mds.22133
DO  - doi:10.1002/mds.22133
SP  - S1
EP  - S422
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstracts 544 - 1089
JO  - American Journal of Transplantation
VL  - 4
IS  - s8
SN  - 9780470662793
UR  - https://doi.org/10.1111/j.1600-6135.2004.0480b.x
DO  - doi:10.1111/j.1600-6135.2004.0480b.x
SP  - 308
EP  - 456
PY  - 2004
ER  - 

TY  - JOUR
TI  - ePresentation Sessions
JO  - European Journal of Neurology
JA  - Eur J Neurol
VL  - 26
IS  - S1
SN  - 9780470662793
UR  - https://doi.org/10.1111/ene.14018
DO  - doi:10.1111/ene.14018
SP  - 112
EP  - 346
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Vox Sanguinis
VL  - 103
IS  - s1
SN  - 9780470662793
UR  - https://doi.org/10.1111/j.1423-0410.2012.01615_2.x
DO  - doi:10.1111/j.1423-0410.2012.01615_2.x
SP  - 68
EP  - 271
PY  - 2012
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Transplant International
JA  - Transpl Int
VL  - 27
IS  - s2
SN  - 9780470662793
UR  - https://doi.org/10.1111/tri.12426
DO  - doi:10.1111/tri.12426
SP  - 13
EP  - 28
PY  - 2014
ER  - 

TY  - JOUR
TI  - E-Poster Exhibition | APDW 2019
JO  - Journal of Gastroenterology and Hepatology
JA  - Journal of Gastroenterology and Hepatology
VL  - 34
IS  - S3
SN  - 9780470662793
UR  - https://doi.org/10.1111/jgh.14865
DO  - doi:10.1111/jgh.14865
SP  - 583
EP  - 853
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders
JO  - Movement Disorders
JA  - Mov. Disord.
VL  - 22
IS  - S16
SN  - 9780470662793
UR  - https://doi.org/10.1002/mds.21535
DO  - doi:10.1002/mds.21535
SP  - S1
EP  - S325
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts of the IPOS 12th World Congress of Psycho-Oncology, 25–29 May 2010, Quebec City, QC, Canada
JO  - Psycho-Oncology
JA  - Psycho‐Oncology
VL  - 19
IS  - S2
SN  - 9780470662793
UR  - https://doi.org/10.1002/pon.1776
DO  - doi:10.1002/pon.1776
SP  - S1
EP  - S325
PY  - 2010
ER  - 

TY  - JOUR
TI  - POSTERS
JO  - Diabetic Medicine
VL  - 23
IS  - s2
SN  - 9780470662793
UR  - https://doi.org/10.1111/j.1466-5468.2006.01875.x
DO  - doi:10.1111/j.1466-5468.2006.01875.x
SP  - 31
EP  - 138
PY  - 2006
ER  - 
